Wu-Pu Lin
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 2
-
- COVID-19 Clinical Research Studies 2
- Co-authors
- Shan‐Chwen Chang (3 shared papers)Jann‐Tay Wang (3 shared papers)Yee‐Chun Chen (2 shared papers)Yu‐Shan Huang (1 shared paper)Tsai‐Ling Lauderdale (1 shared paper)Chang‐Phone Fung (1 shared paper)Yih‐Ru Shiau (1 shared paper)Huiying Wang (1 shared paper)
- Journals
- PLoS ONE (1 paper)Scientific Reports (1 paper)BMC Infectious Diseases (1 paper)Journal of Microbiology Immunology and Infection (1 paper)Nature Communications (1 paper)
- Partner nations
- TaiwanUnited Arab EmiratesMexico
In The Last Decade
Wu-Pu Lin
5 papers receiving 375 citations
Wu-Pu Lin's Hit Papers
Peers
Comparison fields: 5 of 87
- Applied Microbiology and Biotechnology 23
- Molecular Medicine 51
- Infectious Diseases 162
- Neurology 59
- Clinical Biochemistry 19
Countries citing papers authored by Wu-Pu Lin
This map shows the geographic impact of Wu-Pu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wu-Pu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wu-Pu Lin more than expected).
Fields of papers citing papers by Wu-Pu Lin
This network shows the impact of papers produced by Wu-Pu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wu-Pu Lin. The network helps show where Wu-Pu Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Wu-Pu Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials Hit paper breakdown → | 2021 | 216 |
| 2 | 2020 | 66 | |
| 3 | 2016 | 50 | |
| 4 | 2019 | 29 | |
| 5 | 2017 | 23 |
About Wu-Pu Lin
Wu-Pu Lin is a scholar working on Molecular Medicine, Infectious Diseases, Emergency Medical Services, Epidemiology and Neurology, having authored 5 papers that have together received 384 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (2 papers), COVID-19 Clinical Research Studies (2 papers), Central Venous Catheters and Hemodialysis (1 paper), Antibiotics Pharmacokinetics and Efficacy (1 paper), Long-Term Effects of COVID-19 (1 paper), Sepsis Diagnosis and Treatment (1 paper) and Pneumonia and Respiratory Infections (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (23 citations), Molecular Medicine (51 citations), Infectious Diseases (162 citations), Neurology (59 citations) and Clinical Biochemistry (19 citations). Wu-Pu Lin has collaborated with scholars based in Taiwan, United Arab Emirates and Mexico. Frequent co-authors include Shan‐Chwen Chang, Jann‐Tay Wang, Yee‐Chun Chen, Yu‐Shan Huang, Tsai‐Ling Lauderdale, Chang‐Phone Fung, Yih‐Ru Shiau, Huiying Wang, Yao-Shen Chen and Jui‐Fen Lai. Their work appears in journals such as PLoS ONE, Scientific Reports, BMC Infectious Diseases, Journal of Microbiology Immunology and Infection and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.